These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 12061301)
1. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates. Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301 [TBL] [Abstract][Full Text] [Related]
2. Radionuclide therapy of hepatocellular carcinoma. Keng GH; Sundram FX Ann Acad Med Singap; 2003 Jul; 32(4):518-24. PubMed ID: 12968558 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Lau WY; Lai EC; Leung TW; Yu SC Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922 [TBL] [Abstract][Full Text] [Related]
4. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study. Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884 [TBL] [Abstract][Full Text] [Related]
5. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma. Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708 [TBL] [Abstract][Full Text] [Related]
6. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study. Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lau WY; Leung TW; Ho SK; Chan M; Machin D; Lau J; Chan AT; Yeo W; Mok TS; Yu SC; Leung NW; Johnson PJ Lancet; 1999 Mar; 353(9155):797-801. PubMed ID: 10459961 [TBL] [Abstract][Full Text] [Related]
8. 131-iodine Lipiodol therapy in hepatocellular carcinoma. Raoul JL; Boucher E; Roland V; Garin E Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315 [TBL] [Abstract][Full Text] [Related]
9. Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma: a comparative analysis. Chua TC; Saxena A; Chu F; Butler SP; Quinn RJ; Glenn D; Morris DL Int J Clin Oncol; 2011 Apr; 16(2):125-32. PubMed ID: 21061140 [TBL] [Abstract][Full Text] [Related]
10. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil. Kumar A; Srivastava DN; Bal C J Vasc Interv Radiol; 2006 Jan; 17(1):157-61. PubMed ID: 16415146 [TBL] [Abstract][Full Text] [Related]
12. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Schwartz JD; Beutler AS Anticancer Drugs; 2004 Jun; 15(5):439-52. PubMed ID: 15166617 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals. Lambert B; Van de Wiele C Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):980-9. PubMed ID: 16032439 [TBL] [Abstract][Full Text] [Related]
14. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131]. Werenne X Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570 [TBL] [Abstract][Full Text] [Related]
15. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives]. Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591 [TBL] [Abstract][Full Text] [Related]
16. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma? Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125 [No Abstract] [Full Text] [Related]
17. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599 [TBL] [Abstract][Full Text] [Related]
18. Interventional nuclear medicine in hepatocellular carcinoma and other tumours. Buscombe JR Nucl Med Commun; 2002 Sep; 23(9):837-41. PubMed ID: 12195086 [TBL] [Abstract][Full Text] [Related]